Syros Pharmaceuticals Inc logo

Syros Pharmaceuticals Inc

$ 6.65 -0.08 (-1.19%) 04:00 PM EST
P/E:
At Loss
P/B:
1.38
Market Cap:
$ 135.00M
Enterprise V:
$ 114.93M
Volume:
124.48K
Avg Vol (2M):
284.76K
Also Trade In:
Volume:
124.48K
Market Cap $:
135.00M
PE Ratio:
At Loss
Avg Vol (2-Month):
284.76K
Enterprise Value $:
114.93M
PB Ratio:
1.38
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is primarily involved in the segments of the pharmaceutical, biotechnology, and other related markets that address gene control and cancer. The Company operates only in the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 1.34
Equity-to-Asset 0.25
Debt-to-Equity 2.08
Debt-to-EBITDA -0.63
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -7
Distress
Grey
Safe
Beneish M-Score -3.09
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 65.03
9-Day RSI 54.76
14-Day RSI 49.44
6-1 Month Momentum % -33.59
12-1 Month Momentum % -83.97

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.36
Quick Ratio 2.36
Cash Ratio 2.22

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -22.5

Financials (Next Earnings Date:2022-11-04 Est.)

SYRS's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SYRS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 25.242
EPS (TTM) ($) -17.2
Beta 1.49
Volatility % 56.31
14-Day RSI 49.44
14-Day ATR ($) 0.667995
20-Day SMA ($) 6.45375
12-1 Month Momentum % -83.97
52-Week Range ($) 5.25 - 48
Shares Outstanding (Mil) 20.3

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Syros Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Syros Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.